Wearable Tied to Better Physical Activity Recovery Following Lung Cancer Surgery
By Lori Solomon HealthDay Reporter
WEDNESDAY, Sept. 25, 2024 -- A postoperative wearable device may improve physical activity and patient-reported dyspnea at six months after lung cancer surgery, according to a study published online Sept. 20 in JAMA Network Open.
Junghee Lee, M.D., from the Sungkyunkwan University School of Medicine in Seoul, South Korea, and colleagues evaluated the effects of a wearable device intervention on the recovery of physical activity, cardiopulmonary function, and health-related quality of life after lung cancer surgery. Thr analysis included 74 patients with suspected or confirmed non-small cell lung cancer scheduled for curative surgery more extensive than lobectomy and 120 controls not using the wearable intervention.
The researchers found that daily steps, moderate-to-vigorous physical activity, and six-minute walking distance decreased initially at two weeks after surgery but increased thereafter. Compared with the intervention group, the control group had a larger decrease in the number of daily steps from baseline (−4,877 versus −1,753 steps) at two weeks after surgery. The intervention group increased their daily steps by 2,220 from baseline to six months after surgery, while the control group did not return to their baseline number of steps. The intervention group also had better patient-reported physical function, less dyspnea, and less pain at two weeks after surgery and less dyspnea at six months after surgery versus the control group.
"This finding suggests a promising role for wearable devices in personalizing perioperative rehabilitation strategies," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2024
Read this next
UBE Microdiscectomy Beneficial for Lumbar Disc Herniation
TUESDAY, Sept. 24, 2024 -- For adults with symptomatic lumbar disc herniation, unilateral biportal endoscopic (UBE) microdiscectomy is associated with longer operating times and...
Study: Five-Year Survival for Face Transplant Is 85 Percent
TUESDAY, Sept. 24, 2024 -- The overall survival for face transplants is encouraging, with 10-year survival at 74 percent, according to a study published online Sept. 18...
Adjuvant Durvalumab Extends Survival in Small Cell Lung Cancer
THURSDAY, Sept. 19, 2024 -- For patients with limited-stage small cell lung cancer, adjuvant therapy with durvalumab leads to significantly longer overall and progression-free...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.